Genotyping Assays Market Size to Hit USD 71.16 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Genotyping Assays Market

5.1. COVID-19 Landscape: Genotyping Assays Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Genotyping Assays Market, By Technology

8.1. Genotyping Assays Market Revenue and Volume, by Technology

8.1.1. Polymerase Chain Reaction (PCR)

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Microarray

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Next-Generation Sequencing (NGS)

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Mass Spectrometry

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Electrophoresis

8.1.5.1. Market Revenue and Volume Forecast

8.1.6. MALDI-TOF

8.1.6.1. Market Revenue and Volume Forecast

8.1.7. Others

8.1.7.1. Market Revenue and Volume Forecast

Chapter 9. Global Genotyping Assays Market, By Product

9.1. Genotyping Assays Market Revenue and Volume, by Product

9.1.1. Instruments

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Reagents & Kits

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Software & Services

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Genotyping Assays Market, By Application

10.1. Genotyping Assays Market Revenue and Volume, by Application

10.1.1. Pharmacogenomics

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Diagnostics

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Animal Genetics

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Agricultural Biotechnology

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Research (Academic & Clinical)

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global Genotyping Assays Market, By End User

11.1. Genotyping Assays Market Revenue and Volume, by End User

11.1.1. Pharmaceutical & Biopharmaceutical Companies

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Diagnostic Laboratories

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Academic & Research Institutions

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Academic & Research Institutions

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Contract Research Organizations (CROs)

11.1.5.1. Market Revenue and Volume Forecast

11.1.6. Others

11.1.6.1. Market Revenue and Volume Forecast

Chapter 12. Global Genotyping Assays Market, By Workflow Stage

12.1. Genotyping Assays Market Revenue and Volume, by Workflow Stage

12.1.1. Sample Preparation

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. DNA Amplification

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Genotyping/Detection

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Data Analysis & Interpretation

12.1.4.1. Market Revenue and Volume Forecast

Chapter 13. Global Genotyping Assays Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Technology

13.1.2. Market Revenue and Volume Forecast, by Product

13.1.3. Market Revenue and Volume Forecast, by Application

13.1.4. Market Revenue and Volume Forecast, by End User

13.1.5. Market Revenue and Volume Forecast, by Workflow Stage

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Technology

13.1.6.2. Market Revenue and Volume Forecast, by Product

13.1.6.3. Market Revenue and Volume Forecast, by Application

13.1.6.4. Market Revenue and Volume Forecast, by End User

13.1.6.5. Market Revenue and Volume Forecast, by Workflow Stage

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Technology

13.1.7.2. Market Revenue and Volume Forecast, by Product

13.1.7.3. Market Revenue and Volume Forecast, by Application

13.1.7.4. Market Revenue and Volume Forecast, by End User

13.1.7.5. Market Revenue and Volume Forecast, by Workflow Stage

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Technology

13.2.2. Market Revenue and Volume Forecast, by Product

13.2.3. Market Revenue and Volume Forecast, by Application

13.2.4. Market Revenue and Volume Forecast, by End User

13.2.5. Market Revenue and Volume Forecast, by Workflow Stage

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Technology

13.2.6.2. Market Revenue and Volume Forecast, by Product

13.2.6.3. Market Revenue and Volume Forecast, by Application

13.2.7. Market Revenue and Volume Forecast, by End User

13.2.8. Market Revenue and Volume Forecast, by Workflow Stage

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Technology

13.2.9.2. Market Revenue and Volume Forecast, by Product

13.2.9.3. Market Revenue and Volume Forecast, by Application

13.2.10. Market Revenue and Volume Forecast, by End User

13.2.11. Market Revenue and Volume Forecast, by Workflow Stage

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Technology

13.2.12.2. Market Revenue and Volume Forecast, by Product

13.2.12.3. Market Revenue and Volume Forecast, by Application

13.2.12.4. Market Revenue and Volume Forecast, by End User

13.2.13. Market Revenue and Volume Forecast, by Workflow Stage

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Technology

13.2.14.2. Market Revenue and Volume Forecast, by Product

13.2.14.3. Market Revenue and Volume Forecast, by Application

13.2.14.4. Market Revenue and Volume Forecast, by End User

13.2.15. Market Revenue and Volume Forecast, by Workflow Stage

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Technology

13.3.2. Market Revenue and Volume Forecast, by Product

13.3.3. Market Revenue and Volume Forecast, by Application

13.3.4. Market Revenue and Volume Forecast, by End User

13.3.5. Market Revenue and Volume Forecast, by Workflow Stage

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Technology

13.3.6.2. Market Revenue and Volume Forecast, by Product

13.3.6.3. Market Revenue and Volume Forecast, by Application

13.3.6.4. Market Revenue and Volume Forecast, by End User

13.3.7. Market Revenue and Volume Forecast, by Workflow Stage

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Technology

13.3.8.2. Market Revenue and Volume Forecast, by Product

13.3.8.3. Market Revenue and Volume Forecast, by Application

13.3.8.4. Market Revenue and Volume Forecast, by End User

13.3.9. Market Revenue and Volume Forecast, by Workflow Stage

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Technology

13.3.10.2. Market Revenue and Volume Forecast, by Product

13.3.10.3. Market Revenue and Volume Forecast, by Application

13.3.10.4. Market Revenue and Volume Forecast, by End User

13.3.10.5. Market Revenue and Volume Forecast, by Workflow Stage

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Technology

13.3.11.2. Market Revenue and Volume Forecast, by Product

13.3.11.3. Market Revenue and Volume Forecast, by Application

13.3.11.4. Market Revenue and Volume Forecast, by End User

13.3.11.5. Market Revenue and Volume Forecast, by Workflow Stage

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Technology

13.4.2. Market Revenue and Volume Forecast, by Product

13.4.3. Market Revenue and Volume Forecast, by Application

13.4.4. Market Revenue and Volume Forecast, by End User

13.4.5. Market Revenue and Volume Forecast, by Workflow Stage

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Technology

13.4.6.2. Market Revenue and Volume Forecast, by Product

13.4.6.3. Market Revenue and Volume Forecast, by Application

13.4.6.4. Market Revenue and Volume Forecast, by End User

13.4.7. Market Revenue and Volume Forecast, by Workflow Stage

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Technology

13.4.8.2. Market Revenue and Volume Forecast, by Product

13.4.8.3. Market Revenue and Volume Forecast, by Application

13.4.8.4. Market Revenue and Volume Forecast, by End User

13.4.9. Market Revenue and Volume Forecast, by Workflow Stage

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Technology

13.4.10.2. Market Revenue and Volume Forecast, by Product

13.4.10.3. Market Revenue and Volume Forecast, by Application

13.4.10.4. Market Revenue and Volume Forecast, by End User

13.4.10.5. Market Revenue and Volume Forecast, by Workflow Stage

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Technology

13.4.11.2. Market Revenue and Volume Forecast, by Product

13.4.11.3. Market Revenue and Volume Forecast, by Application

13.4.11.4. Market Revenue and Volume Forecast, by End User

13.4.11.5. Market Revenue and Volume Forecast, by Workflow Stage

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Technology

13.5.2. Market Revenue and Volume Forecast, by Product

13.5.3. Market Revenue and Volume Forecast, by Application

13.5.4. Market Revenue and Volume Forecast, by End User

13.5.5. Market Revenue and Volume Forecast, by Workflow Stage

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Technology

13.5.6.2. Market Revenue and Volume Forecast, by Product

13.5.6.3. Market Revenue and Volume Forecast, by Application

13.5.6.4. Market Revenue and Volume Forecast, by End User

13.5.7. Market Revenue and Volume Forecast, by Workflow Stage

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Technology

13.5.8.2. Market Revenue and Volume Forecast, by Product

13.5.8.3. Market Revenue and Volume Forecast, by Application

13.5.8.4. Market Revenue and Volume Forecast, by End User

13.5.8.5. Market Revenue and Volume Forecast, by Workflow Stage

Chapter 14. Company Profiles

14.1. Thermo Fisher Scientific

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Illumina Inc.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Bio-Rad Laboratories Inc.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Agilent Technologies

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. QIAGEN

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Danaher Corporation

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. PerkinElmer Inc.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Roche Diagnostics

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Takara Bio Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Fluidigm Corporation

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The genotyping assays market size is expected to increase from USD 19.45 billion in 2024 to USD 71.16 billion by 2034.

The genotyping assays market is expected to grow at a compound annual growth rate (CAGR) of around 13.85% from 2025 to 2034.

The major players in the genotyping assays market include Thermo Fisher Scientific, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies, QIAGEN, Danaher Corporation, PerkinElmer Inc., Roche Diagnostics, Takara Bio Inc., Fluidigm Corporation, Luminex Corporation, Pacific Biosciences, BGI Genomics, Genewiz (Part of Azenta Life Sciences), Sequenom (A Laboratory Corporation of America Holdings subsidiary), Affymetrix (now part of Thermo Fisher), Eurofins Genomics, Analytik Jena, Merck KGaA, and New England Biolabs.

The driving factors of the genotyping assays market are the rising demand for personalized medicine, increasing prevalence of genetic disorders, advancements in genomics technologies, and expanding applications in drug development.

North America region will lead the global genotyping assays market during the forecast period 2025 to 2034.